Enviva Inc – (EVA, +1, Dec 5th)
Jeffrey Ubben (Director since 2020) purchased 228,697 shares, $12.5 million worth of stock on December 2nd at $54.78, increasing his holdings to 5.8m shares (8% of the company). The purchase is indirect for Inclusive Capital and follows purchases of $15.3 million in October at $50.64. This is now a complete reversal from a timely sale of 501,691 shares in March 2022 at $75.
Also buying shares in October were Edward Smith (VP of Operations), John Bumgarder (Director), Ralph Alexander (Director), Shai Even (CFO), John Keppler (Chair and CEO), Thomas Meth (President) and William Schmidt (General Counsel). In October these purchases from insiders, excluding Ubben, totaled $2.3m. We ranked this stock +1 on June 27th based on purchases from Meth, Even, and Keppler around $59 per share.
We are renewing our +1 rank led by Ubben’s aggressive reversal.